Faron Pharmaceuticals Oy (DI) (FARN)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

152.50p
   
  • Change Today:
      5.50p
  • 52 Week High: 350.00p
  • 52 Week Low: 92.50p
  • Currency: UK Pounds
  • Shares Issued: 104.62m
  • Volume: 100,377
  • Market Cap: £159.55m

Latest ShareCast News

Faron gets positive FDA feedback on bexmarilimab study plans

By Josh White

Date: Thursday 11 Jul 2024

(Sharecast News) - Faron Pharmaceuticals announced positive feedback from the FDA regarding the clinical development plan for its drug candidate bexmarilimab, aimed at treating myelodysplastic syndrome (MDS), on Thursday.

Faron Pharmaceuticals extends funding agreement with IPF

By Josh White

Date: Tuesday 30 Apr 2024

(Sharecast News) - Faron Pharmaceuticals announced on Tuesday that it has extended its agreement with lender IPF to ensure continued financial support as it progressed towards securing longer-term funding.

Faron Pharmaceuticals CFO stands down

By Iain Gilbert

Date: Monday 15 Apr 2024

(Sharecast News) - Clinical-stage biopharmaceutical company Faron Pharmaceuticals revealed on Monday that chief financial officer James O'Brien would be leaving the group to "pursue another career opportunity".

Faron Pharmaceuticals taps Juho Jalkanen for CEO 08-Apr-2024 ShareCast
Faron shares jump on encouraging trial data 18-Mar-2024 ShareCast
Faron Pharmaceuticals reports year of clinical p... 13-Mar-2024 ShareCast
Faron Pharmaceuticals shores up cash with EUR 3.... 04-Mar-2024 ShareCast
Faron launches second phase of leukaemia treatme... 09-Jan-2024 ShareCast
Faron unveils promising antibody study results 11-Dec-2023 ShareCast
Faron publishes cancer immunotherapy study findi... 07-Dec-2023 ShareCast
Faron reveals details of next stage of bexmarili... 06-Nov-2023 ShareCast
Faron Pharmaceuticals upbeat on latest data in b... 11-Oct-2023 ShareCast
Faron Pharmaceuticals names interim chief medica... 21-Sep-2023 ShareCast
Faron Pharmaceuticals names James O'Brien as CFO 29-Mar-2023 ShareCast
Faron Pharmaceuticals gets positive feedback fro... 22-Mar-2023 ShareCast
Faron upbeat on updated data from cancer treatme... 23-Feb-2022 ShareCast
Marie-Louise Fjallskog tapped as Faron's new chi... 04-Jan-2022 ShareCast
Faron Pharmaceuticals wins dispute with Rentschl... 09-Nov-2021 ShareCast
Faron doses first patient in Covid-19 treatment ... 25-Aug-2021 ShareCast
New research supports mode of action in Faron's ... 03-Jun-2021 ShareCast
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

FARN Market Data

Currency UK Pounds
Share Price 152.50p
Change Today 5.50p
% Change 3.74 %
52 Week High 350.00p
52 Week Low 92.50p
Volume 100,377
Shares Issued 104.62m
Market Cap £159.55m

FARN Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
Market averageMarket averageMarket averageMarket averageMarket average
52.94% below the sector average52.94% below the sector average52.94% below the sector average52.94% below the sector average52.94% below the sector average
Price Trend
Market averageMarket averageMarket averageMarket averageMarket average
23.08% below the sector average23.08% below the sector average23.08% below the sector average23.08% below the sector average23.08% below the sector average
Income Not Available
Growth Not Available

What The Brokers Say

Strong Buy 1
Buy 1
Neutral 0
Sell 0
Strong Sell 1
Total 3
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

FARN Dividends

No dividends found

Trades for 26-Jul-2024

Time Volume / Share Price
15:32 9,530 @ 152.10p
16:25 3,290 @ 152.13p
16:23 3,076 @ 152.13p
16:18 451 @ 155.00p
16:15 981 @ 155.00p

FARN Key Personnel

CEO Juho Jalkanen
Chair Tuomo Pätsi

Top of Page